The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

Hope Funds for Cancer Research announce James D. Watson Award

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

THE HOPE FUNDS FOR CANCER RESEARCH announced the creation of the James D. Watson Award, with Nobel laureate James Watson being the first recipient.

The award honors Watson for his contributions to the field of biology and cancer research and will be awarded to scientists who make comparable seminal discoveries. The award will be presented at the organization’s annual awards dinner on April 24 in New York City.

Watson is best known as a co-discoverer of the structure of DNA in 1953 with Francis Crick. He was awarded the 1962 Nobel Prize in Physiology or Medicine along with Crick and Maurice Wilkins.

Table of Contents

YOU MAY BE INTERESTED IN

PodcastThe Directors

The Directors: Steven Artandi and Eric Winer on how looming policy changes “reverberate” through oncology
“Even when funding gets restored and if the H-1B visa threat doesn’t materialize, it creates an environment where especially young people become uncertain.”

With major leadership changes, grant disruptions and terminations, and a stoked distrust in science, Steven Artandi, the director of Stanford Cancer Center, worries that young investigators will feel disenchanted by the U.S. research atmosphere and take their work and study elsewhere. 
By Claire Marie Porter and Paul Goldberg
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account